Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adcetris
Biotech
ASCO: It's back to the basics for cancer drug developers
This year’s American Society of Clinical Oncology conference in Chicago marked a return to its pre-pandemic heyday.
Gabrielle Masson
Jun 5, 2024 10:55am
ASCO: Takeda Oncology ready to stoke partnerships
Jun 9, 2022 7:30am
Tubulis lands $63M to advance ADC pipeline led by Adcetris rival
May 3, 2022 5:00am
Tubulis raises A round to advance next-gen ADC programs
Jul 21, 2020 7:25am
Seattle buys Cascadian and its breast cancer program for $614M
Jan 31, 2018 7:03am
